MedPath

Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials

Not Applicable
Recruiting
Conditions
Cancer
Malignant Neoplasm
Malignancy
Registration Number
NCT05886764
Lead Sponsor
University of Chicago
Brief Summary

This trial will study different outreach methods to assess impact on enrollment of underrepresented minorities (specifically African Americans) to early phase cancer clinical treatment trials. Both patients and providers (those seeing enrolled patients) will be enrolled and receive the study interventions or no intervention (control arm).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percentage of patients that enroll to early phase cancer treatment clinical trials.within 2 months of randomization
Secondary Outcome Measures
NameTimeMethod
Number of successfully completed outreach effortsafter 30 participants are enrolled to each of arms 2 and 3
Percent change in number of African Americans that enroll to cancer clinical trials2 years after study start
Percentage of patients that enroll to early phase cancer treatment clinical trials post intervention.2 years from randomization

Trial Locations

Locations (1)

University of Chicago Medicine Comprehensive Cancer Center

🇺🇸

Chicago, Illinois, United States

University of Chicago Medicine Comprehensive Cancer Center
🇺🇸Chicago, Illinois, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.